Procter & Gamble
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Procter & Gamble
Errors Coughed Up For Dextromethorphan, Guaifenesin In US FDA Electronic Registrations
Three of seven businesses warned since February 2022 about noncompliance with FDA drug reporting requirements have been marketers of OTC cough/cold/congestion formulations made with dextromethorphan or guaifenesin.
P&G Looks To Change Children’s Toothpaste Market With Crest Kids Color Changing
Color of the toothpaste, which P&G North America oral care chief says is “only one of its kind on the market today,” changes from blue to pink after two minutes of brushing.
Sen. Murray ‘Watching Closely’ For US FDA To Implement, Enforce Cosmetics Regulatory Reform
Senate HELP chair Patty Murray says she will ensure FDA implements cosmetics reform correctly and “effectively” uses enforcement tools. EWG exec says previous standards didn’t address “chronic harm caused by a known carcinogen like benzene.”
Looking Beyond The Deal In England
Agreement of deals that promise better value for money and enhanced patient access to new treatments has become routine in England, but are they delivering?
- OTC, Consumer
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.